GB201517873D0 - Epilepsy Biomarker - Google Patents

Epilepsy Biomarker

Info

Publication number
GB201517873D0
GB201517873D0 GBGB1517873.4A GB201517873A GB201517873D0 GB 201517873 D0 GB201517873 D0 GB 201517873D0 GB 201517873 A GB201517873 A GB 201517873A GB 201517873 D0 GB201517873 D0 GB 201517873D0
Authority
GB
United Kingdom
Prior art keywords
biomarker
epilepsy
epilepsy biomarker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1517873.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kings College London
Original Assignee
Kings College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kings College London filed Critical Kings College London
Priority to GBGB1517873.4A priority Critical patent/GB201517873D0/en
Publication of GB201517873D0 publication Critical patent/GB201517873D0/en
Priority to PCT/GB2016/053132 priority patent/WO2017060727A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1517873.4A 2015-10-09 2015-10-09 Epilepsy Biomarker Ceased GB201517873D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1517873.4A GB201517873D0 (en) 2015-10-09 2015-10-09 Epilepsy Biomarker
PCT/GB2016/053132 WO2017060727A1 (en) 2015-10-09 2016-10-07 Epilepsy biomarker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1517873.4A GB201517873D0 (en) 2015-10-09 2015-10-09 Epilepsy Biomarker

Publications (1)

Publication Number Publication Date
GB201517873D0 true GB201517873D0 (en) 2015-11-25

Family

ID=55130810

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1517873.4A Ceased GB201517873D0 (en) 2015-10-09 2015-10-09 Epilepsy Biomarker

Country Status (2)

Country Link
GB (1) GB201517873D0 (en)
WO (1) WO2017060727A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106995936B (en) * 2017-05-17 2019-05-14 中南大学湘雅医院 A kind of epilepsy encephalopathy genetic chip and its application
CN113322315A (en) * 2021-06-04 2021-08-31 上海浦东解码生命科学研究院 Detection product and method for epilepsy medication related SNP locus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010071881A1 (en) * 2008-12-19 2010-06-24 Columbia University Method for confirming a diagnosis of rolandic epilepsy

Also Published As

Publication number Publication date
WO2017060727A1 (en) 2017-04-13

Similar Documents

Publication Publication Date Title
PL3261455T3 (en) Allulose syrups
HK1252089A1 (en) Solid forms
GB2566681B (en) Biomarker
GB201420908D0 (en) Biomarkers
GB201401603D0 (en) Biomarkers
ZA202001821B (en) Biomarker
HK1251001A1 (en) Il-37 variants
GB201710858D0 (en) Biomarker
GB201507032D0 (en) Allulose syrups
GB201500729D0 (en) Novel Biomarkers
GB201416015D0 (en) Biomarker
GB201517873D0 (en) Epilepsy Biomarker
GB201512133D0 (en) Biomarkers
GB201420239D0 (en) Biomarker
GB201707113D0 (en) Biomarker
GB201521446D0 (en) Biomarker
GB201519704D0 (en) Biomarkers
GB201516841D0 (en) Novel biomarker
GB201513683D0 (en) Biomarkers
GB201501511D0 (en) Biomarker
GB201501480D0 (en) Biomarker
GB201519595D0 (en) It
GB201519507D0 (en) it
GB201519371D0 (en) It
GB201519278D0 (en) It

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)